-
February 14, 2022 That Time Snoop Dogg Ate Mushrooms and Cried Backstage"I don't even know what got into my emotions, but I felt so good, and...
-
February 4, 2022 Psychedelic Business Spotlight – February 4Levitee Labs Announces Interim CEO and Board of Directors ShuffleThis week in psychedelic business news,...
-
January 28, 2022 Psychedelic Business Spotlight — January 28This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one...
-
January 25, 2022 How Rick Doblin Guides Someone Through a Bad Psychedelic TripDifficult trips could be a problem in areas where psychedelics have been decriminalized, which is...
-
January 21, 2022 Psychedelic Business Spotlight – January 21Catch up on some of the biggest psychedelic business developments that unfolded in the last...
-
January 20, 2022 DEA Proposes Adding 5 More Psychedelics to Schedule 1 Controlled SubstancesAgency argues these five tryptamines "have no known medical use," setting up a showdown with...
-
January 19, 2022 Majority of Mental Health Patients Support Access to Psychedelics, Survey FindsAmericans continue to open their minds to ketamine, psilocybin, and MDMA treatment for depression, anxiety,...
-
January 5, 2022 Psychedelics Will Have a Big Presence at SXSW in 2022Tim Ferriss and Roland Griffiths are among the biggest names in the burgeoning psychedelics movement...
-
January 5, 2022 Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic CompoundsIt’s yet another sign that the pharmaceutical industry at large is taking the potential of...
-
January 4, 2022 Health Canada Grants Special Access to Restricted Drugs for Psychedelic TherapyNew amendment reverses a 2013 Health Canada policy that prevented "a letter of authorization for...
